Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium.

The €115 million grant, titled Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials), will increase our understanding of autism and help develop new therapies to improve health outcomes and quality of life for autistic people.

The consortium is academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, and involves the Oxford Translational Molecular Neuroscience Group (Nuffield Department of Clinical Neurosciences). 

Associate Professor Zameel Cader, Nuffield Department of Clinical Neurosciences commented: 'The Oxford Translational Molecular Neuroscience Group will undertake the stem cell disease modelling for this consortium to understand gene/environment interactions in autism. The goal is to identify biomarkers and targets that may enable stratified clinical trials and personalised medicine in autism.'

Find out more (Nuffield Department of Clinical Neurosciences website)

Similar stories

No limit to the benefits of exercise in reducing the risk of cardiovascular disease

General Research

A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.’

Accurate predictions of ovarian cancer outcome possible with new classification system

General Research

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.

Accidental awareness in obstetric surgery under general anaesthesia more frequent than expected

General Research

The largest ever study of awareness during obstetric general anaesthesia shows around 1 in 250 women may be affected, and some may experience long-term psychological harm.